trial · primary record
Apalutamide
Prostatic Neoplasms
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 1503 |
| Primary completion | 2028-12-29 |
| Primary endpoint | Metastasis-Free Survival (MFS) |
| Registry ID | NCT02531516 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:46.308Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02531516
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Apalutamide · compound